Fibrinogen, an endogenous ligand of Toll-like receptor 4, activates monocytes in pre-eclamptic patients

Journal of Reproductive Immunology

Volumn 103, Issue 1, 2014, Pages 23-28

  Al ofi, Ebtisam ^a   Coffelt, Seth B ^a,b   Anumba, Dilly O ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b Division of Immunology   (Netherlands)

Author keywords

Fibrinogen; Monocytes; Pre eclampsia; Pregnancy disorders; TLR4

Indexed keywords

FIBRINOGEN; FIBRONECTIN; HEPARAN SULFATE; TOLL LIKE RECEPTOR 4; CYTOKINE; TLR4 PROTEIN, HUMAN;

ADULT; ARTICLE; CELL ACTIVATION; CELL ISOLATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MONOCYTE; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; BIOSYNTHESIS; BLOOD; HYPERTENSION; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; PREGNANCY; PROTEINURIA;

ADULT; CYTOKINES; FEMALE; FIBRINOGEN; FIBRONECTINS; HEPARITIN SULFATE; HUMANS; HYPERTENSION; INFLAMMATION; MONOCYTES; PRE-ECLAMPSIA; PREGNANCY; PROTEINURIA; TOLL-LIKE RECEPTOR 4;

EID: 84900307476     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2014.02.004     Document Type: Article

References (43)

1. Al-ofi E., et al. Monocyte subpopulations from pre-eclamptic patients are abnormally skewed and exhibit exaggerated responses to toll-like receptor ligands. PLoS One 2012, 7:e42217.
2. Barrera V., et al. Host fibrinogen stably bound to hemozoin rapidly activates monocytes via tlr-4 and cd11b/cd18-integrin: a new paradigm of hemozoin action. Blood 2011, 117:5674-5682.
3. Bonnar J., et al. Coagulation and fibrinolytic systems in pre-eclampsia and eclampsia. Br. Med. J. 1971, 2:12-16.
4. Bosisio D., et al. Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-gamma: a molecular basis for priming and synergism with bacterial lipopolysaccharide. Blood 2002, 99:3427-3431.
5. Carty D.M., et al. Urinary proteomics for prediction of preeclampsia. Hypertension 2011, 57:561-569.
6. Chen Y.H., et al. Pneumonia and pregnancy outcomes: a nationwide population-based study. Am. J. Obstet. Gynecol. 2012, 207(28):e1-e7.
7. Conrad K.P., et al. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am. J. Reprod. Immunol. 1998, 40:102-111.
8. Donnelly J.C., et al. Circulating pro- and anticoagulant levels in normal and complicated primigravid pregnancies and their relationship to placental pathology. J. Obstet. Gynaecol. 2013, 33:264-268.
9. Erridge C. Endogenous ligands of tlr2 and tlr4: agonists or assistants?. J. Leukoc. Biol. 2010, 87:989-999.
10. Fan S.T., Edgington T.S. Integrin regulation of leukocyte inflammatory functions. Cd11b/cd18 enhancement of the tumor necrosis factor-alpha responses of monocytes. J. Immunol. 1993, 150:2972-2980.
11. Freeman D.J., et al. Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension 2004, 44:708-714.
12. Gervasi M.T., et al. Phenotypic and metabolic characteristics of maternal monocytes and granulocytes in preterm labor with intact membranes. Am. J. Obstet. Gynecol. 2001, 185:1124-1129.
13. Greer I.A., et al. Neutrophil activation is confined to the maternal circulation in pregnancy-induced hypertension. Obstet. Gynecol. 1991, 78:28-32.
14. Greer I.A., et al. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction?. Obstet. Gynecol. 1994, 84:937-940.
15. Guzzo C., et al. Il-27 enhances lps-induced proinflammatory cytokine production via upregulation of tlr4 expression and signaling in human monocytes. J. Immunol. 2012, 188:864-873.
16. Hale S.A., et al. Coagulation and fibrinolytic system protein profiles in women with normal pregnancies and pregnancies complicated by hypertension. Pregnancy Hypertens. 2012, 2:152-157.
17. Heilmann L., et al. Hemostatic abnormalities in patients with severe preeclampsia. Clin. Appl. Thromb. Hemost. 2007, 13:285-291.
18. Hodgkinson C.P., et al. Functional toll-like receptor 4 mutations modulate the response to fibrinogen. Thromb. Haemost. 2008, 100:301-307.
19. Jonsson Y., et al. Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J. Reprod. Immunol. 2006, 70:83-91.
20. Karehed K., et al. Fibrinogen and histidine-rich glycoprotein in early-onset preeclampsia. Acta Obstet. Gynecol. Scand. 2010, 89:131-139.
21. Kuhns D.B., et al. Induction of human monocyte interleukin (IL)-8 by fibrinogen through the toll-like receptor pathway. Inflammation 2007, 30:178-188.
22. Kumar A., et al. IL-10, TNF-alpha & IFN-gamma: potential early biomarkers for preeclampsia. Cell. Immunol. 2013, 283:70-74.
23. Kupferminc M.J., et al. Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia. Obstet. Gynecol. 1996, 88:420-427.
24. Lishko V.K., et al. Multiple binding sites in fibrinogen for integrin alphambeta2 (Mac-1). J. Biol. Chem. 2004, 279:44897-44906.
25. Luppi P., Deloia J.A. Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines. Clin. Immunol. 2006, 118:268-275.
26. Luppi P., et al. Monocytes are progressively activated in the circulation of pregnant women. J. Leukoc. Biol. 2002, 72:874-884.
27. Millien V.O., et al. Cleavage of fibrinogen by proteinases elicits allergic responses through toll-like receptor 4. Science 2013, 341:792-796.
28. Minassian C., et al. Acute maternal infection and risk of pre-eclampsia: a population-based case-control study. PLoS One 2013, 8:e73047.
29. Perez R.L., Roman J. Fibrin enhances the expression of IL-1 beta by human peripheral blood mononuclear cells. Implications in pulmonary inflammation. J. Immunol. 1995, 154:1879-1887.
30. Perez R.L., et al. Transcriptional regulation of the interleukin-1beta promoter via fibrinogen engagement of the CD18 integrin receptor. Am. J. Respir. Cell Mol. Biol. 1999, 20:1059-1066.
31. Redman C.W. Preeclampsia: a multi-stress disorder. Rev. Med. Interne 2011, 32(Suppl. 1):S41L 4.
32. Saito S., et al. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin. Exp. Immunol. 1999, 117:550-555.
33. Schjetlein R., et al. Markers of intravascular coagulation and fibrinolysis in preeclampsia: association with intrauterine growth retardation. Acta Obstet. Gynecol. Scand. 1997, 76:541-546.
34. Sibai B., et al. Pre-eclampsia. Lancet 2005, 365:785-799.
35. Smiley S.T., et al. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol. 2001, 167:2887-2894.
36. Szarka A., et al. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol. 2010, 11:59.
37. Thorburn J., et al. Blood viscosity and haemostatic factors in late pregnancy, pre-eclampsia and fetal growth retardation. Br. J. Obstet. Gynaecol. 1982, 89:117-122.
38. Ustun Y., et al. Association of fibrinogen and c-reactive protein with severity of preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 2005, 121:154-158.
39. Vince G.S., et al. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br. J. Obstet. Gynaecol. 1995, 102:20-25.
40. Visintin A., et al. Regulation of toll-like receptors in human monocytes and dendritic cells. J. Immunol. 2001, 166:249-255.
41. Von Dadelszen P., et al. Levels of antibodies against cytomegalovirus and chlamydophila pneumoniae are increased in early onset pre-eclampsia. BJOG 2003, 110:725-730.
42. Wegmann T.G., et al. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon?. Immunol. Today 1993, 14:353-356.
43. Xiao J.P., et al. The increased maternal serum levels of IL-6 are associated with the severity and onset of preeclampsia. Cytokine 2012, 60:856-860.